Zobrazeno 1 - 10
of 62
pro vyhledávání: '"S. Yu. Serebrova"'
Autor:
G. I. Gorodetskaya, A. B. Prokofiev, S. Yu. Serebrova, E. Yu. Demchenkova, M. V. Zhuravleva, O. A. Demidova, T. V. Alexandrova, I. A. Mazerkina, E. A. Sokova, O. V. Muslimova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 1, Pp 105-120 (2023)
Cephalosporins are the empirical antibiotic therapy (ABT) of choice for patients with community-acquired pneumonia (CAP). When treated with antibiotics, elderly patients, especially those with comorbidities, are at higher risk of developing adverse d
Externí odkaz:
https://doaj.org/article/914e335edbe740be9a9fb6b5f7fa7c48
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 200-205 (2022)
Introduction. In the context of a pandemic, it is necessary to quickly and accurately stratify patients into groups based on the severity of their condition and prognostic risk. For these purposes, some available biomarkers, such as proadrenomedullin
Externí odkaz:
https://doaj.org/article/003f845a030440099a9450109f9534a0
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 76-83 (2022)
Introduction. The diagnosis of alcohol-related liver disease is limited by the lack of a tool to reliably identify whether the present deterioration in the patient’s condition is due to alcohol consumption or other causes.Purpose. to conduct a comp
Externí odkaz:
https://doaj.org/article/4ed4cdd2c9014733a29603f11bab02e3
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 200-208 (2021)
Currently, lactulose is known to most as a laxative that has a hyperosmotic effect, stimulating intestinal peristalsis. The drug has long established itself as a safe and effective medicine. Lactulose is one of the few drugs that is approved for use
Externí odkaz:
https://doaj.org/article/0954dbdd24d34c3ca09fab68feb31c01
Autor:
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, I. A. Komissarenko, E. V. Shikh, A. K. Starodubtsev
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 155-164 (2021)
Introduction. IBS is a functional bowel disorder that has a significant impact on patients and society, especially in terms of quality of life and medical costs.Pathogenesis. It is believed that the pathogenesis of IBS consists of several mechanisms:
Externí odkaz:
https://doaj.org/article/493aa35f94784b46a1572a233ade7504
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 124-133 (2021)
TNF-α has been known since 1985. It is a multifunctional proinflammatory cytokine, synthesized mainly by monocytes and macrophages. Since its discovery, many studies have been conducted that have proven that it provides homeostatic function and regu
Externí odkaz:
https://doaj.org/article/5bdd13e60563493dbf8387b0cf54ddf1
Autor:
E. Yu. Demchenkova, G. I. Gorodetskaya, I. A. Mazerkina, M. V. Zhuravleva, A. S. Kazakov, M. V. Gorodetskiy, L. Yu. Badriddinova, S. Yu. Serebrova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 9, Iss 1, Pp 34-42 (2021)
Widespread use of cephalosporin antibiotics in clinical practice calls for greater attention to the risk of adverse drug reactions. Information on serious or unexpected adverse events reported during post-marketing experience is submitted to national
Externí odkaz:
https://doaj.org/article/ab77cd53a2b8429695f47ccbb7203f7e
Publikováno v:
Медицинский совет, Vol 0, Iss 18, Pp 115-121 (2020)
Severe bronchial asthma in children remains a serious problem, which is caused by high mortality, side effects from therapy with high doses of glucocorticosteroids and a significant consumption of health resources. According to statistics from the Mo
Externí odkaz:
https://doaj.org/article/f24ff2ce15af403c85a816c10f487613
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 47-53 (2020)
Main groups of antisecretory drugs used in the treatment of acid-dependent diseases, including gastroesophageal reflux disease (GERD), are described in a review. Mechanisms of activation, degradation and inactive metabolites formation of proton pump
Externí odkaz:
https://doaj.org/article/07dad150458f4d949d8457cd4e512885
Autor:
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 4, Pp 644-653 (2020)
Current guidelines for the management of patients with dyslipidemia define low-density lipoprotein cholesterol (LDL-C) as the primary target in addressing lipid-lowering therapy. The target level of LDL-C in real clinical practice is achieved in no m
Externí odkaz:
https://doaj.org/article/15478c1651fe4908a9cf25ab6956f073